KAUST and Janssen Pharmaceutical (Johnson & Johnson) are collaborating to research and innovate in neglected tropical diseases, focusing on dengue fever. They signed an MoU to establish a dengue fever research program and an infectious disease R&D center at KAUST's National BioPark. The partnership marks Johnson & Johnson's first university collaboration in Saudi Arabia. Why it matters: This collaboration signifies a major step in localizing disease research within Saudi Arabia and leveraging KAUST's AI, genomics, and data simulation expertise to address global health challenges.
KAUST and King Abdulaziz University (KAU) have signed a memorandum of understanding (MoU) to collaborate and fund scientific research. The collaboration will focus on areas including cancer research, energy harvesting and storage, solar technology, renewable energy, and desert agriculture. The MoU was signed by Donal Bradley, KAUST VP for Research, and Yusuf Al Turki, KAU VP for Graduate Studies and Scientific Research. Why it matters: This partnership between two leading Saudi universities will help advance research and development in areas critical to Saudi Vision 2030.
KAUST and Jeddah Yacht Club and Marina signed an MOU to collaborate on research, knowledge exchange, and educational programs. The agreement aims to strengthen the partnership between the two organizations, opening opportunities for collaboration and knowledge sharing. The partnership aligns with Saudi Vision 2030's goals for environmental sustainability and quality of life improvements. Why it matters: This MOU represents a diversification of KAUST's partnerships, extending beyond purely technological domains to support tourism and recreation in line with national priorities.
KAUST's Bioscience Core Lab (BCL) supports regional and global health initiatives through industry partnerships, offering expertise and technology access to organizations like SaudiVax. BCL aids SaudiVax in developing vaccines and monoclonal antibodies tailored to the needs of Saudi Arabia and the MENA region, focusing on respiratory diseases like MERS and COVID-19. SaudiVax is also collaborating with KAUST to research a new preventative drug targeting SARS-CoV-2. Why it matters: This strengthens Saudi Arabia's capabilities in vaccine development and biomanufacturing, addressing critical healthcare needs in the region and reducing reliance on external sources.
KAUST and Boeing renewed their Master Research Agreement (MRA) on September 1. The agreement aims to boost collaborative research on next-generation aerospace technologies. The renewed MRA signifies a continued partnership between the Saudi university and the American aerospace company. Why it matters: This agreement can foster innovation in aerospace within Saudi Arabia and aligns with the Kingdom's broader technology development goals.